What to expect at the live educational session
Hear from an Incyte Oncology Nurse Educator who may be able to help answer your questions.
|LEARN about PV and MF|
|CONNECT with people like you and learn how to partner with your healthcare professional|
|EXPLORE some select treatment options, including Jakafi|
|DISCUSS the importance of a management plan and setting goals|
The speaker will not provide medical advice. Your healthcare professional is the best source of information about your health.
Only your healthcare professional can decide if Jakafi is right for you.
Jakafi is a prescription medicine used to treat adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it.
Jakafi is used to treat adults with certain types of myelofibrosis.
Jakafi is also used to treat adults and children 12 years of age and older with acute graft-versus-host disease (GVHD) who have taken corticosteroids and they did not work well enough.
What is Jakafi?
Jakafi is the first and only prescription medicine for treatment of adults with polycythemia vera who have already taken a medicine called hydroxyurea and it did not work well enough or they could not tolerate it. Jakafi is also the first prescription medicine approved to treat adults with intermediate or high-risk myelofibrosis.
FIND A SESSION NEAR YOU
Please complete and submit the registration form below